1naresh2naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

    [e8eb5c66-8775-4ae6-afc2-9ce1a4f4d77e] => Array
        (
            [runtime-id] => e8eb5c66-8775-4ae6-afc2-9ce1a4f4d77e
            [type] => toll-free-key
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [3269490d-af6f-48ab-b845-aba4e02202af] => Array
                        (
                            [runtime-id] => 3269490d-af6f-48ab-b845-aba4e02202af
                            [type] => toll-free-key
                        )

                )

            [credentials] => Array
                (
                    [method] => toll-free-key
                    [value] => tf_ipsecsha;596212af418febbc3e96dc4d4c895ff183d42abf
                )

        )

)
1naresh2naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

    [e8eb5c66-8775-4ae6-afc2-9ce1a4f4d77e] => Array
        (
            [runtime-id] => e8eb5c66-8775-4ae6-afc2-9ce1a4f4d77e
            [type] => toll-free-key
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [3269490d-af6f-48ab-b845-aba4e02202af] => Array
                        (
                            [runtime-id] => 3269490d-af6f-48ab-b845-aba4e02202af
                            [type] => toll-free-key
                        )

                )

            [credentials] => Array
                (
                    [method] => toll-free-key
                    [value] => tf_ipsecsha;596212af418febbc3e96dc4d4c895ff183d42abf
                )

        )

)
1naresh2naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

    [e8eb5c66-8775-4ae6-afc2-9ce1a4f4d77e] => Array
        (
            [runtime-id] => e8eb5c66-8775-4ae6-afc2-9ce1a4f4d77e
            [type] => toll-free-key
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [3269490d-af6f-48ab-b845-aba4e02202af] => Array
                        (
                            [runtime-id] => 3269490d-af6f-48ab-b845-aba4e02202af
                            [type] => toll-free-key
                        )

                )

            [credentials] => Array
                (
                    [method] => toll-free-key
                    [value] => tf_ipsecsha;596212af418febbc3e96dc4d4c895ff183d42abf
                )

        )

)
1naresh2naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

    [e8eb5c66-8775-4ae6-afc2-9ce1a4f4d77e] => Array
        (
            [runtime-id] => e8eb5c66-8775-4ae6-afc2-9ce1a4f4d77e
            [type] => toll-free-key
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [3269490d-af6f-48ab-b845-aba4e02202af] => Array
                        (
                            [runtime-id] => 3269490d-af6f-48ab-b845-aba4e02202af
                            [type] => toll-free-key
                        )

                )

            [credentials] => Array
                (
                    [method] => toll-free-key
                    [value] => tf_ipsecsha;596212af418febbc3e96dc4d4c895ff183d42abf
                )

        )

)
1naresh2naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => FreeToRead
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

    [1038ad94-344b-41e5-9c4f-8a30bd225ec0] => Array
        (
            [runtime-id] => 1038ad94-344b-41e5-9c4f-8a30bd225ec0
            [type] => toll-free-key
            [service-id] => ajnr-ac.highwire.org
            [access-type] => FreeToRead
            [privilege] => Array
                (
                    [73dfff57-396b-4d5d-8ff1-076033b11e5c] => Array
                        (
                            [runtime-id] => 73dfff57-396b-4d5d-8ff1-076033b11e5c
                            [type] => toll-free-key
                        )

                )

            [credentials] => Array
                (
                    [method] => toll-free-key
                    [value] => tf_ipsecsha;596212af418febbc3e96dc4d4c895ff183d42abf
                )

        )

)


  
    











































































































































    Brain Volume and Diffusion Markers as Predictors of Disability and Short-Term Disease Evolution in Multiple Sclerosis | American Journal of Neuroradiology  
    



















    































    
  
  




    
    

  

      


    

      

  
  
  

    

  

    

  

                
    

      

  

    

  
      
  
  

    


Advertisement



  



  


  
  



  



    

  


  


  


  
  
  
  
  
  

  	      



          


    
      

    
  
    
        
    

  

    
                        

  

                
    

      

	  

		
		

			

			  

  
      
  
  

    

  
  
      
Research ArticleBrain

  
      

  
      
Brain Volume and Diffusion Markers as Predictors of Disability and Short-Term Disease Evolution in Multiple Sclerosis
  
    	
P.G. Sämann, M. Knop, E. Golgor, S. Messler, M. Czisch and F. Weber

  
    	
American Journal of Neuroradiology August 2012,  33 (7) 1356-1362; DOI: https://doi.org/10.3174/ajnr.A2972 

  
  
  



  


  
  



			

		

	
	
 	
	  
  

		
		

			

			  

  
      
  
  

    
  


  
  



  
      
  
  

    

  

    

  
      
  
  

    
References
  1. 1.↵


    1. Hauser  SL, 
    2. Oksenberg  JR
    . The neurobiology of multiple sclerosis: genes, inflammation, and neurodegeneration. Neuron 2006;52:61–76
    CrossRefPubMedWeb of Science
  2. 2.↵


    1. Anderson  VM, 
    2. Fox  NC, 
    3. Miller  DH
    . Magnetic resonance imaging measures of brain atrophy in multiple sclerosis. J Magn Reson Imaging 2006;23:605–18
    CrossRefPubMedWeb of Science
  3. 3.↵


    1. Trapp  BD, 
    2. Ransohoff  R, 
    3. Rudick  R
    . Axonal pathology in multiple sclerosis: relationship to neurologic disability. Curr Opin Neurol 1999;12:295–302
    CrossRefPubMedWeb of Science
  4. 4.↵


    1. Miller  DH, 
    2. Barkhof  F, 
    3. Frank  JA, 
    4. et al
    . Measurement of atrophy in multiple sclerosis: pathological basis, methodological aspects and clinical relevance. Brain 2002;125:1676–95
    Abstract/FREE Full Text
  5. 5.↵


    1. Rovaris  M, 
    2. Gass  A, 
    3. Bammer  R, 
    4. et al
    . Diffusion MRI in multiple sclerosis. Neurology 2005;65:1526–32
    Abstract/FREE Full Text
  6. 6.↵


    1. Kalkers  NF, 
    2. Ameziane  N, 
    3. Bot  JC, 
    4. et al
    . Longitudinal brain volume measurement in multiple sclerosis: rate of brain atrophy is independent of the disease subtype. Arch Neurol 2002;59:1572–76
    CrossRefPubMedWeb of Science
  7. 7.↵


    1. Chard  DT, 
    2. Griffin  CM, 
    3. Parker  GJ, 
    4. et al
    . Brain atrophy in clinically early relapsing-remitting multiple sclerosis. Brain 2002;125:327–37
    Abstract/FREE Full Text
  8. 8.↵


    1. De Stefano  N, 
    2. Matthews  PM, 
    3. Filippi  M, 
    4. et al
    . Evidence of early cortical atrophy in MS: relevance to white matter changes and disability. Neurology 2003;60:1157–62
    Abstract/FREE Full Text
  9. 9.↵


    1. Zivadinov  R, 
    2. Sepcic  J, 
    3. Nasuelli  D, 
    4. et al
    . A longitudinal study of brain atrophy and cognitive disturbances in the early phase of relapsing-remitting multiple sclerosis. J Neurol Neurosurg Psychiatry 2001;70:773–80
    Abstract/FREE Full Text
  10. 10.↵


    1. Sastre-Garriga  J, 
    2. Ingle  GT, 
    3. Chard  DT, 
    4. et al
    . Grey and white matter atrophy in early clinical stages of primary progressive multiple sclerosis. Neuroimage 2004;22:353–59
    CrossRefPubMedWeb of Science
  11. 11.↵


    1. Richert  ND, 
    2. Howard  T, 
    3. Frank  JA, 
    4. et al
    . Relationship between inflammatory lesions and cerebral atrophy in multiple sclerosis. Neurology 2006;66:551–56
    Abstract/FREE Full Text
  12. 12.↵


    1. De Stefano  N, 
    2. Iannucci  G, 
    3. Sormani  MP, 
    4. et al
    . MR correlates of cerebral atrophy in patients with multiple sclerosis. J Neurol 2002;249:1072–77
    CrossRefPubMedWeb of Science
  13. 13.↵


    1. Bielekova  B, 
    2. Kadom  N, 
    3. Fisher  E, 
    4. et al
    . MRI as a marker for disease heterogeneity in multiple sclerosis. Neurology 2005;65:1071–76
    Abstract/FREE Full Text
  14. 14.↵


    1. Fisher  E, 
    2. Rudick  RA, 
    3. Simon  JH, 
    4. et al
    . Eight-year follow-up study of brain atrophy in patients with MS. Neurology 2002;59:1412–20
    Abstract/FREE Full Text
  15. 15.↵


    1. Horakova  D, 
    2. Dwyer  MG, 
    3. Havrdova  E, 
    4. et al
    . Gray matter atrophy and disability progression in patients with early relapsing-remitting multiple sclerosis: a 5-year longitudinal study. J Neurol Sci 2009;282:112–19
    CrossRefPubMed
  16. 16.↵


    1. Ciccarelli  O, 
    2. Werring  DJ, 
    3. Wheeler-Kingshott  CA, 
    4. et al
    . Investigation of MS normal-appearing brain using diffusion tensor MRI with clinical correlations. Neurology 2001;56:926–33
    Abstract/FREE Full Text
  17. 17.↵


    1. Tortorella  P, 
    2. Rocca  MA, 
    3. Mezzapesa  DM, 
    4. et al
    . MRI quantification of gray and white matter damage in patients with early-onset multiple sclerosis. J Neurol 2006;253:903–07
    CrossRefPubMedWeb of Science
  18. 18.↵


    1. Cercignani  M, 
    2. Inglese  M, 
    3. Pagani  E, 
    4. et al
    . Mean diffusivity and fractional anisotropy histograms of patients with multiple sclerosis. AJNR Am J Neuroradiol 2001;22:952–58
    Abstract/FREE Full Text
  19. 19.↵


    1. Budde  MD, 
    2. Kim  JH, 
    3. Liang  HF, 
    4. et al
    . Axonal injury detected by in vivo diffusion tensor imaging correlates with neurological disability in a mouse model of multiple sclerosis. NMR Biomed 2008;21:589–97
    CrossRefPubMedWeb of Science
  20. 20.↵


    1. Phuttharak  W, 
    2. Galassi  W, 
    3. Laopaiboon  V, 
    4. et al
    . ADC measurements in various patterns of multiple sclerosis lesions. J Med Assoc Thai 2006;89:196–204
    PubMed
  21. 21.↵


    1. Nusbaum  AO, 
    2. Lu  D, 
    3. Tang  CY, 
    4. et al
    . Quantitative diffusion measurements in focal multiple sclerosis lesions: correlations with appearance on TI-weighted MR images. AJR Am J Roentgenol 2000;175:821–25
    CrossRefPubMedWeb of Science
  22. 22.↵


    1. Vrenken  H, 
    2. Pouwels  PJ, 
    3. Geurts  JJ, 
    4. et al
    . Altered diffusion tensor in multiple sclerosis normal-appearing brain tissue: cortical diffusion changes seem related to clinical deterioration. J Magn Reson Imaging 2006;23:628–36
    CrossRefPubMedWeb of Science
  23. 23.↵


    1. Tavazzi  E, 
    2. Dwyer  MG, 
    3. Weinstock-Guttman  B, 
    4. et al
    . Quantitative diffusion weighted imaging measures in patients with multiple sclerosis. Neuroimage 2007;36:746–54
    CrossRefPubMedWeb of Science
  24. 24.↵


    1. Wilson  M, 
    2. Morgan  PS, 
    3. Lin  X, 
    4. et al
    . Quantitative diffusion weighted magnetic resonance imaging, cerebral atrophy, and disability in multiple sclerosis. J Neurol Neurosurg Psychiatry 2001;70:318–22
    Abstract/FREE Full Text
  25. 25.↵


    1. Oreja-Guevara  C, 
    2. Rovaris  M, 
    3. Iannucci  G, 
    4. et al
    . Progressive gray matter damage in patients with relapsing-remitting multiple sclerosis: a longitudinal diffusion tensor magnetic resonance imaging study. Arch Neurol 2005;62:578–84
    CrossRefPubMedWeb of Science
  26. 26.↵


    1. Rovaris  M, 
    2. Judica  E, 
    3. Gallo  A, 
    4. et al
    . Grey matter damage predicts the evolution of primary progressive multiple sclerosis at 5 years. Brain 2006;129:2628–34
    Abstract/FREE Full Text
  27. 27.↵


    1. Fischer  JS, 
    2. Rudick  RA, 
    3. Cutter  GR, 
    4. et al
    . The Multiple Sclerosis Functional Composite Measure (MSFC): an integrated approach to MS clinical outcome assessment—National MS Society Clinical Outcomes Assessment Task Force. Mult Scler 1999;5:244–50
    Abstract/FREE Full Text
  28. 28.↵


    1. Cassol  E, 
    2. Ranjeva  JP, 
    3. Ibarrola  D, 
    4. et al
    . Diffusion tensor imaging in multiple sclerosis: a tool for monitoring changes in normal-appearing white matter. Mult Scler 2004;10:188–96
    Abstract/FREE Full Text
  29. 29.↵


    1. Gallo  A, 
    2. Rovaris  M, 
    3. Riva  R, 
    4. et al
    . Diffusion-tensor magnetic resonance imaging detects normal-appearing white matter damage unrelated to short-term disease activity in patients at the earliest clinical stage of multiple sclerosis. Arch Neurol 2005;62:803–08
    CrossRefPubMedWeb of Science
  30. 30.↵


    1. Bermel  RA, 
    2. Puli  SR, 
    3. Rudick  RA, 
    4. et al
    . Prediction of longitudinal brain atrophy in multiple sclerosis by gray matter magnetic resonance imaging T2 hypointensity. Arch Neurol 2005;62:1371–76
    CrossRefPubMedWeb of Science
  31. 31.↵


    1. Tiberio  M, 
    2. Chard  DT, 
    3. Altmann  DR, 
    4. et al
    . Gray and white matter volume changes in early RRMS: a 2-year longitudinal study. Neurology 2005;64:1001–07
    Abstract/FREE Full Text
  32. 32.↵


    1. Chard  DT, 
    2. Griffin  CM, 
    3. Rashid  W, 
    4. et al
    . Progressive grey matter atrophy in clinically early relapsing-remitting multiple sclerosis. Mult Scler 2004;10:387–91
    Abstract/FREE Full Text
  33. 33.↵


    1. Paolillo  A, 
    2. Pozzilli  C, 
    3. Giugni  E, 
    4. et al
    . A 6-year clinical and MRI follow-up study of patients with relapsing-remitting multiple sclerosis treated with interferon-beta. Eur J Neurol 2002;9:645–55
    CrossRefPubMedWeb of Science
  34. 34.↵


    1. Quarantelli  M, 
    2. Ciarmiello  A, 
    3. Morra  VB, 
    4. et al
    . Brain tissue volume changes in relapsing-remitting multiple sclerosis: correlation with lesion load. Neuroimage 2003;18:360–66
    CrossRefPubMed
  35. 35.↵


    1. Lukas  C, 
    2. Minneboo  A, 
    3. de Groot  V, 
    4. et al
    . Early central atrophy rate predicts 5 year clinical outcome in multiple sclerosis. J Neurol Neurosurg Psychiatry 2010;81:1351–56.
Epub 2010 Sep 8
    Abstract/FREE Full Text
  36. 36.↵


    1. Mesaros  S, 
    2. Rocca  MA, 
    3. Sormani  MP, 
    4. et al
    . Clinical and conventional MRI predictors of disability and brain atrophy accumulation in RRMS: a large scale, short-term follow-up study. J Neurol 2008;255:1378–83
    CrossRefPubMedWeb of Science
  37. 37.↵


    1. Rovaris  M, 
    2. Gallo  A, 
    3. Valsasina  P, 
    4. et al
    . Short-term accrual of gray matter pathology in patients with progressive multiple sclerosis: an in vivo study using diffusion tensor MRI. Neuroimage 2005;24:1139–46
    CrossRefPubMedWeb of Science
  38. 38.↵


    1. McDonald  WI, 
    2. Compston  A, 
    3. Edan  G, 
    4. et al
    . Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the Diagnosis of Multiple Sclerosis. Ann Neurol 2001;50:121–27
    CrossRefPubMedWeb of Science
  39. 39.↵


    1. Garaci  FG, 
    2. Colangelo  V, 
    3. Ludovici  A, 
    4. et al
    . A diffusion longitudinal MR imaging study in normal-appearing white matter in untreated relapsing-remitting multiple sclerosis. AJNR Am J Neuroradiol 2007;28:475–78
    Abstract/FREE Full Text
  40. 40.↵


    1. Kurtzke  JF
    . Rating neurological impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983;33:1444–52
    Abstract/FREE Full Text
  41. 41.↵


    1. Chabriat  H, 
    2. Pappata  S, 
    3. Poupon  C, 
    4. et al
    . Clinical severity in CADASIL related to ultrastructural damage in white matter: in vivo study with diffusion tensor MRI. Stroke 1999;30:2637–43
    Abstract/FREE Full Text
  42. 42.↵


    1. Chard  DT, 
    2. Parker  GJ, 
    3. Griffin  CM, 
    4. et al
    . The reproducibility and sensitivity of brain tissue volume measurements derived from an SPM-based segmentation methodology. J Magn Reson Imaging 2002;15:259–67
    CrossRefPubMedWeb of Science
  43. 43.↵


    1. Smith  SM, 
    2. Zhang  Y, 
    3. Jenkinson  M, 
    4. et al
    . Accurate, robust, and automated longitudinal and cross-sectional brain change analysis. Neuroimage 2002;17:479–89
    CrossRefPubMedWeb of Science
  44. 44.↵


    1. Van Leemput  K, 
    2. Maes  F, 
    3. Vandermeulen  D, 
    4. et al
    . Automated segmentation of multiple sclerosis lesions by model outlier detection. IEEE Trans Med Imaging 2001;20:677–88
    CrossRefPubMedWeb of Science
  45. 45.↵


    1. Cercignani  M, 
    2. Bozzali  M, 
    3. Iannucci  G, 
    4. et al
    . Magnetisation transfer ratio and mean diffusivity of normal appearing white and grey matter from patients with multiple sclerosis. J Neurol Neurosurg Psychiatry 2001;70:311–17
    Abstract/FREE Full Text
  46. 46.↵


    1. Griffin  CM, 
    2. Chard  DT, 
    3. Ciccarelli  O, 
    4. et al
    . Diffusion tensor imaging in early relapsing-remitting multiple sclerosis. Mult Scler 2001;7:290–97
    Abstract/FREE Full Text
  47. 47.↵


    1. van Waesberghe  JH, 
    2. Kamphorst  W, 
    3. De Groot  CJ, 
    4. et al
    . Axonal loss in multiple sclerosis lesions: magnetic resonance imaging insights into substrates of disability. Ann Neurol 1999;46:747–54
    CrossRefPubMedWeb of Science
  48. 48.↵


    1. Rudick  RA, 
    2. Fisher  E, 
    3. Lee  JC, 
    4. et al
    . Use of the brain parenchymal fraction to measure whole brain atrophy in relapsing-remitting MS. Multiple Sclerosis Collaborative Research Group. Neurology 1999;53:1698–704
    Abstract/FREE Full Text
  49. 49.↵


    1. Guttmann  CR, 
    2. Meier  DS, 
    3. Holland  CM
    . Can MRI reveal phenotypes of multiple sclerosis? Magn Reson Imaging 2006;24:475–81
    CrossRefPubMed
  50. 50.↵


    1. Simon  JH, 
    2. Jacobs  LD, 
    3. Campion  MK, 
    4. et al
    . A longitudinal study of brain atrophy in relapsing multiple sclerosis: the Multiple Sclerosis Collaborative Research Group (MSCRG). Neurology 1999;53:139–48
    Abstract/FREE Full Text
  51. 51.↵


    1. Kalkers  NF, 
    2. Vrenken  H, 
    3. Uitdehaag  BM, 
    4. et al
    . Brain atrophy in multiple sclerosis: impact of lesions and of damage of whole brain tissue. Mult Scler 2002;8:410–14
    Abstract/FREE Full Text
  52. 52.↵


    1. Kalkers  NF, 
    2. Bergers  E, 
    3. Castelijns  JA, 
    4. et al
    . Optimizing the association between disability and biological markers in MS. Neurology 2001;57:1253–58
    Abstract/FREE Full Text
  53. 53.↵


    1. Hildebrandt  H, 
    2. Hahn  HK, 
    3. Kraus  JA, 
    4. et al
    . Memory performance in multiple sclerosis patients correlates with central brain atrophy. Mult Scler 2006;12:428–36
    Abstract/FREE Full Text
  54. 54.↵


    1. Lazeron  RH, 
    2. Boringa  JB, 
    3. Schouten  M, 
    4. et al
    . Brain atrophy and lesion load as explaining parameters for cognitive impairment in multiple sclerosis. Mult Scler 2005;11:524–31
    Abstract/FREE Full Text
  55. 55.↵


    1. Kalkers  NF, 
    2. de Groot  V, 
    3. Lazeron  RH, 
    4. et al
    . MS functional composite: relation to disease phenotype and disability strata. Neurology 2000;54:1233–39
    Abstract/FREE Full Text
  56. 56.↵


    1. Schmierer  K, 
    2. Altmann  DR, 
    3. Kassim  N, 
    4. et al
    . Progressive change in primary progressive multiple sclerosis normal-appearing white matter: a serial diffusion magnetic resonance imaging study. Mult Scler 2004;10:182–87
    Abstract/FREE Full Text
  57. 57.↵


    1. Molyneux  PD, 
    2. Kappos  L, 
    3. Polman  C, 
    4. et al
    . The effect of interferon beta-1b treatment on MRI measures of cerebral atrophy in secondary progressive multiple sclerosis: European Study Group on Interferon Beta-1b in Secondary Progressive Multiple Sclerosis. Brain 2000;123
(pt 11):
2256–63
    Abstract/FREE Full Text
  58. 58.↵


    1. Rovaris  M, 
    2. Confavreux  C, 
    3. Furlan  R, 
    4. et al
    . Secondary progressive multiple sclerosis: current knowledge and future challenges. Lancet Neurol 2006;5:343–54
    CrossRefPubMedWeb of Science
  59. 59.↵


    1. Dichgans  M, 
    2. Putz  B, 
    3. Boos  D, 
    4. et al
    . Role of subvoxel free fluid on diffusion parameters in brain tissue with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy and its correlation with physical disability: histogram analysis of standard and fluid-attenuated MR diffusion. AJNR Am J Neuroradiol 2003;24:1083–89
    Abstract/FREE Full Text
  


  
  



  




  


  
  



  
      
  
  

    
  


  
  



  
      
  
  

     Back to top  


  
  



			

		

		
		

			

			  

  
        
In this issue

    
  
  

    
  


  
  



  
      
  
  

    

  

    

  
      
  
  

    


Advertisement



  



  


  
  



  



  


  
  



  
      
  
  

    

	  
  

		

          

            

  
      
  
  

     Print  


  
  



  
      
  
  

     Download PDF  


  
  



  
      
  
  

    
 Email Article
  


  
  



  
      
  
  

    
 Citation Tools
  


  
  



          

        

        
        

          

            



  
      
  
  

    

  

    

  
      
  
  

    

  
  
  
  
      
Brain Volume and Diffusion Markers as Predictors of Disability and Short-Term Disease Evolution in Multiple Sclerosis
  
    	
P.G. Sämann, M. Knop, E. Golgor, S. Messler, M. Czisch, F. Weber

  
    	
American Journal of Neuroradiology Aug 2012, 33 (7) 1356-1362; DOI: 10.3174/ajnr.A2972 

  
  
  



  


  
  



  
      
  
  

    

  
    
  
  
    
  
  
    
  


  


  
  



  
      
  
  

    
del.icio.us logo Twitter logo Facebook logo Mendeley logo
  


  
  



  



  


  
  



  
      
  
  

    
  


  
  



          

        

	
 	
	
	


  


  
  



  
      
  
  

    
              Purchase  


  
  



  
        
Jump to section

    
  
  

    
  


  
  



  
      
  
  

    
  


  
  



			

		

	
	
 	
	
	


    

  



  

                
    

      

  

    

  
      
  
  

    


Advertisement